Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors (Q31960434)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors (English)
1 reference
F A Eskens
1 reference
A Awada
1 reference
D L Cutler
1 reference
M J de Jonge
1 reference
G P Luyten
1 reference
M N Faber
1 reference
P Statkevich
1 reference
A Sparreboom
1 reference
J Verweij
1 reference
A R Hanauske
1 reference
M Piccart
1 reference
European Organization for Research and Treatment of Cancer Early Clinical Studies Group
1 reference
1 February 2001
1 reference
1 reference
Identifiers
1 reference